The purpose of this contract is the acquisition of vaccines to supply the needs of the year 2023.

Acquisition of 130,000 doses of hexavalent vaccine (DTa-PI-Hib-HB)

Purchase of 4,000 doses of hemodialysis hepatitis B vaccine

Acquisition of 10,000 doses of adult hepatitis A+B vaccine

Acquisition of 2,000 doses of paediatric hepatitis A+B vaccine

Purchase of 8,000 doses of injectable polio vaccine (Salk type)

Purchase of 20,000 doses of injectable typhoid vaccine

Acquisition of 6,000 doses of Japanese encephalitic vaccine

Purchase of 16,000 doses of yellow fever vaccine

Purchase of 320 doses of Central European encephalitis vaccine for adults

Purchase of 320 doses of Central European encephalitis vaccine for children

Acquisition of 500 doses of rotavirus vaccine

Acquisition of 1,500 doses of haemophilus influenzae type B vaccine

Acquisition of 75,000 doses of diphtheria, tetanus, acellular pertussis vaccine

(DTPa) y antipoliomielítica (PI)

Acquisition of 275,000 doses of inactivated influenza vaccine produced from viruses

grown in embryonated eggs, fractionated viruses or surface antigens (H and N) or

analogues containing 4 strains of influenza virus. Territorial scope: Barcelona

Procurement of 323,000 doses of inactivated influenza vaccine produced from viruses

grown in embryonated eggs, fractionated viruses or surface antigens (H and N) or

analogues containing 4 strains of influenza virus. Territorial scope: Tarragona and

West Coast

Acquisition of 297,000 doses of inactivated influenza vaccine produced from viruses

grown in embryonated eggs, fractionated viruses or surface antigens (H and N) or

analogues containing 4 strains of influenza virus. Territorial scope: Girona,

Vallès Oriental and Vallès Occidental

Acquisition of 255,000 doses of inactivated influenza vaccine produced from viruses

grown in embryonated eggs, fractionated viruses or surface antigens (H and N) or

analogues containing 4 strains of influenza virus. Territorial scope: Lleida,

Central Catalonia and Barcelona North and Maresme

Acquisition of 200,000 doses of inactivated influenza vaccine produced from viruses

grown in embryonated eggs with adjuvant, containing 4 strains of

influenza

Acquisition of 250,000 doses of inactivated influenza vaccine produced from viruses

grown in embryonated eggs of high antigenic load, containing 4 strains of

flu virus

Purchase of 135,000 doses of chickenpox vaccine

Procurement of 120,000 doses of tetanus and diphtheria vaccine for adults (Td)

Purchase of 120,000 doses of MMR vaccine

Purchase of 210,000 doses of meningococcal B vaccine

Acquisition of 35,000 doses of pediatric hepatitis A vaccine

Purchase of 35,000 doses of adult hepatitis B vaccine

Purchase of 1,000 doses of paediatric hepatitis B vaccine